Christine Ocampo, Vice President, Finance at AVANIR PHARMACEUTICALS, INC. (AVNR), bought 3,000 shares at $2.60 ($8K) on 2012-03-06, disclosed to the SEC on 2012-03-07.
Open-market purchase of $8k AVNR by Vice President, Finance. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| AVNR | SELL | 2014-10-24 | $25K | — | Filing → |
| AVNR | SELL | 2014-09-17 | $520K | — | Filing → |
| AVNR | SELL | 2014-08-28 | $13K | — | Filing → |